Jim Simons
FFTY icon

Jim Simons’s CapForce IBD 50 ETF FFTY Stock Holding History

Jim Simons’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,300
Closed -$481K – 4331
2022
Q1 		$481K Buy
+12,300
New +$477K ﹤0.01% 3222

Other funds holding FFTY

CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Jim Simons's FFTY Position: Q2 2022 in Review

Jim Simons sold out of CapForce IBD 50 ETF (FFTY) in Q2 2022, closing a stake of 12,300 shares — an estimated $481K sold.

Jim Simons first reported a position in FFTY in Q1 2022 and held it in 1 quarter. The position peaked at $481K in Q1 2022. 58 funds tracked by Wall St. Rank hold FFTY as of Q2 2022.

  • Jim Simons reported no remaining CapForce IBD 50 ETF position as of Q2 2022 after selling out during the quarter.
  • Jim Simons sold 12,300 CapForce IBD 50 ETF shares in Q2 2022, an estimated $481K.
  • Jim Simons first reported a position in CapForce IBD 50 ETF in Q1 2022 and held it in 1 quarter.
  • Jim Simons's CapForce IBD 50 ETF position peaked at $481K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2022.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.